ORIC Pharmaceuticals, Inc(NASDAQ:ORIC) 
ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers. The company's lead product candidate is ORIC-101, a small molecule antagonist of the glucocorticoid receptor, which has been linked to resistance to multiple classes of ...
Website: http://www.oricpharma.com
Full Time Employees: 60
CEO: Jacob M. Chacko
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 5.03
H 5.18
L 4.79
C 4.88
V 1,073,880
10EMA 4.88
20EMA 4.88
60EMA 4.88
120EMA 4.88
250EMA 4.88